NCT00078598View on ClinicalTrials.gov

A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma

PHASE3UnknownINTERVENTIONAL
Enrollment

506

Participants

Timeline

Start Date

April 30, 2004

Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG

Rituximab or Iodine I 131 Tositumomab Therapy

Trial Locations (5)

26506

NOT_YET_RECRUITING

West Virginia University/Mary Babb Randolph Cancer Center, Morgantown

30342

RECRUITING

Northside Hospital, Atlanta

45409

NOT_YET_RECRUITING

Medical Oncology/Hematology Associates, Dayton

98431

NOT_YET_RECRUITING

Madigan Army Medical Center, Tacoma

99362

RECRUITING

St Mary Medical Center/Regional Cancer Center, Walla Walla

Sponsors

Lead Sponsor

Corixa Corporation
All Listed Sponsors
lead

Corixa Corporation

INDUSTRY

NCT00078598 - A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter